Advances in the treatment of male androgenetic alopecia: current options and emerging therapies.

Abstract

Introduction: Androgenetic alopecia (AGA), or pattern hair loss, is the most common form of hair loss worldwide. It is primarily caused by genetic and hormonal factors, particularly the action of dihydrotestosterone (DHT) on hair follicles.

Evidence acquisition: A comprehensive literature search on PubMed and Google Scholar was conducted until October 31, 2024, using keywords related to male AGA and its treatments. Relevant reviews, meta-analyses, clinical trials, and case studies in English were selected and analyzed to enhance the quality of the research. This review is based solely on existing studies and does not include new human or animal research conducted by the authors.

Evidence synthesis: This review thoroughly examined and analyzed 149 articles to provide a detailed presentation of the evidence.

Conclusions: This article examines both established and emerging therapies for AGA. We recommend initiating treatment with topical minoxidil and oral finasteride, as these are extensively researched and FDA-approved options for male AGA. For patients who do not respond well or cannot tolerate these treatments, clinicians may explore alternative therapies and approaches.